Table 2. Patient characteristics at initiation.
Kenya | Uganda | Zambia | Total | |
---|---|---|---|---|
N | 13,135 | 8,097 | 8,275 | 29,507 |
% | % | % | % | |
Female | 65.9 | 61.4 | 58.5 | 62.6 |
Age (median (IQR)) | 35 (28–43) | 35 (29–42) | 36 (30–42) | 35 (29–42) |
18–29 | 28.9 | 27.6 | 23.8 | 27.1 |
30–39 | 37.6 | 39.3 | 43.7 | 39.8 |
40–49 | 22.3 | 22.6 | 22.7 | 22.5 |
50+ | 11.3 | 10.6 | 9.8 | 10.7 |
WHO stage | ||||
I | 20.4 | 20.1 | 24.5 | 21.5 |
II | 32.5 | 34.7 | 23.4 | 30.6 |
III | 33.6 | 29 | 42.3 | 34.8 |
IV | 3.7 | 6.3 | 6.4 | 5.2 |
Missing | 9.7 | 9.8 | 3.5 | 8 |
CD4 count (median(IQR)) | 173 (79–259) | 175 (83–264) | 170 (96–256) | 173 (86–259) |
<50 | 11.8 | 13 | 9 | 11.4 |
50–199 | 27.8 | 28.6 | 41.4 | 31.8 |
200–349 | 23.3 | 25.3 | 27.3 | 25 |
350+ | 5.6 | 6.8 | 6.4 | 6.2 |
Missing | 31.5 | 26.2 | 16 | 25.7 |
Year | ||||
2007 | 14.1 | 3.9 | ||
2008 | 18.6 | 11.8 | 18.9 | 16.8 |
2009 | 20 | 16.4 | 27.3 | 21 |
2010 | 25.9 | 23.1 | 35.5 | 27.8 |
2011 | 29.4 | 33.3 | 4.3 | 23.4 |
2012 | 6.1 | 15.5 | 7 |